ロード中...
Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours
The aim of this open-label phase 1b study was to assess the safety and pharmacokinetics of motesanib in combination with gemcitabine in patients with advanced solid tumours. Eligible patients with histologically or cytologically documented solid tumours or lymphoma were enroled in three sequential,...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
Nature Publishing Group
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2579691/ https://ncbi.nlm.nih.gov/pubmed/18971935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604723 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|